Ruiz-Aragón, J.; Márquez-Peláez, S.; Gani, R.; Alvarez, P.; Guerrero-Luduena, R.
Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain. Vaccines 2022, 10, 176.
https://doi.org/10.3390/vaccines10020176
AMA Style
Ruiz-Aragón J, Márquez-Peláez S, Gani R, Alvarez P, Guerrero-Luduena R.
Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain. Vaccines. 2022; 10(2):176.
https://doi.org/10.3390/vaccines10020176
Chicago/Turabian Style
Ruiz-Aragón, Jesús, Sergio Márquez-Peláez, Ray Gani, Piedad Alvarez, and Richard Guerrero-Luduena.
2022. "Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain" Vaccines 10, no. 2: 176.
https://doi.org/10.3390/vaccines10020176
APA Style
Ruiz-Aragón, J., Márquez-Peláez, S., Gani, R., Alvarez, P., & Guerrero-Luduena, R.
(2022). Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain. Vaccines, 10(2), 176.
https://doi.org/10.3390/vaccines10020176